First Tracks Biotherapeutics, Inc. operates as a clinical-stage biotechnology company developing antibody therapeutics that modulate immune pathways implicated in autoimmune and inflammatory diseases. First Tracks Biotherapeutics, Inc. was ...
Q1 2026
Mar 31, 2026
Q1 2025
Mar 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023